Skip to main content

Table 3 Antithrombotic treatment in the protocol (n = 99) and non-protocol (n = 291) treated groups

From: Safety of the primary percutaneous coronary intervention strategy combining pre-hospital prasugrel, enoxaparin and in-hospital bivalirudin in acute ST-segment elevation myocardial infarction

  Protocol, n (%) Non-protocol, n (%) P-value
First medical contact
 Aspirin 99 (100) 257 (88.3) <0.0001
 Prasugrel loading dose 99 (100) 139 (47.8) <0.0001
 Clopidogrel loading dose 1(1.0) 116 (39.9) <0.0001
 Enoxaparin bolus i.v. 99 (100) 192 (66.0) <0.0001
 Glycoprotein IIb/IIIa inhibitor 0 (0) 15 (5.2) 0.021
Catheter laboratorio
 Bivalirudin 99 (100) 36 (12.4) <0.0001
 Glycoprotein IIb/IIIa inhibitor 6 (6.1) 79 (27.1) <0.0001
 Enoxaparin i.v. 9 (9.1) 56 (19.2) 0.019
 Unfractionated heparin 0 (0) 7 (2.4) 0.119